Ascendis Pharma (ASND) total liabilities

Total liabilities · fiscal 2025
€1.47B

Ascendis Pharma (ASND) had total liabilities of €1.47B at the end of fiscal 2025 (December 31, 2025). That is 14.0% higher than the €1.29B of fiscal 2024. Figures as of 19 Nov 2026, 01:56 UTC, from Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
€1.47B
Change on fiscal 2024
+14.0%
Highest on record
€1.47Bfiscal 2025
Lowest on record
€826.39Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

Ascendis Pharma total liabilities, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €1.47B in fiscal 2025 and the lowest €826.39M in fiscal 2022.

History · 4 fiscal years

Total liabilities by fiscal year

Ascendis Pharma total liabilities, year by year

Ascendis Pharma (ASND) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025€1.47B 14.0% up
2024€1.29B 32.3% up
2023€971.28M 17.5% up
2022€826.39M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Ascendis Pharma and comparable companies
CompanyTotal liabilitiesFiscal year
Revvity RVTY$4.92B2025
Neurocrine Biosciences NBIX$1.38B2025
Ascendis Pharma ASND€1.47B2025
ICON ICLR$7.08B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ASND

Ascendis Pharma, figure by figure

Ascendis Pharma (ASND) overview: price, valuation and scorecardAll health care companies by market value

Ascendis Pharma total liabilities: questions and answers

How large are Ascendis Pharma's total liabilities?

Ascendis Pharma (ASND) had total liabilities of €1.47B at the end of fiscal 2025 (December 31, 2025). That is 14.0% higher than the €1.29B of fiscal 2024.

What are the highest and lowest total liabilities figures on record for Ascendis Pharma?

Across the 4 fiscal years on record (2022–2025), the highest was €1.47B in fiscal 2025 and the lowest €826.39M in fiscal 2022.

How is Ascendis Pharma's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Ascendis Pharma it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ascendis Pharma (ASND) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/ASND/total-liabilities

Underlying data: Yahoo Finance.